Skip to main content
. 2006 Aug;13(8):953–957. doi: 10.1128/CVI.00037-06

TABLE 3.

Analysis of neutralizing capacity of purified M1A toward SARS-CoV

Time % of cellsa with CPE
Normal cells Test group with the following concn of M1A (mg/ml)
Virus control group
1 0.5 0.25 0.03125-0.125
Day 1
Day 2 50 50
Day 3 100 100
Day 4 20 100 100
Day 5 100 100 100
Day 6 100 100 100
a

Normal cells, cells only; virus control group, cells treated with 100 PFU SARS-CoV; test group, cells treated with 100 PFU SARS-CoV and M1A Fab molecule mixture.